Biosimilars Check Up: Physician Survey Results
By AmerisourceBergen |
Learn Physicians’ Perspectives on Biosimilars
To uncover the biggest hurdles facing
biosimilars today, AmerisourceBergen surveyed 100 physicians for their insights
on issues like barriers to adoption and cost. The results reveal a market
that, though not yet mature, has great potential to deliver on the promise of
As stakeholders across healthcare seek to understand how biosimilars can be utilized, it is critical to understand how physicians view these products.